XML 78 R57.htm IDEA: XBRL DOCUMENT v2.3.0.15
Other Intangible Assets (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
year
day
Sep. 30, 2010
Dec. 31, 2010
Dec. 31, 2009
Other Intangible Assets, Net      
Other Intangible Assets, Gross$ 3,379.4 $ 3,379.4 $ 2,678.1 
Finite Lived Intangible Assets Gross3,255.9 3,255.9 2,538.4 
Other Intangible Assets, Accumulated Amortization(817.7) (817.7) (699.2) 
Other Intangible Assets, Net, Total2,561.71,567.22,561.71,567.21,978.91,790.7
Other Intangible Assets, Acquired During Period  717.12.7  
Other Intangible Assets, Impairment Losses16.042.716.042.7  
Other Intangible Assets, Future Amortization Expense183.0     
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in Years)  18   
Specialty Pharmaceuticals
      
Other Intangible Assets, Net      
Other Intangible Assets, Net, Total1,389.5 1,389.5 1,482.9 
Human Genetic Therapies
      
Other Intangible Assets, Net      
Other Intangible Assets, Net, Total470.7 470.7 496.0 
Regenerative Medicine
      
Other Intangible Assets, Net      
Other Intangible Assets, Net, Total701.5 701.5   
Acquired Currently Marketed Products
      
Other Intangible Assets, Net      
Other Intangible Assets, Gross2,522.2 2,522.2 2,516.4 
Acquired In Process Research and Development
      
Other Intangible Assets, Net      
Other Intangible Assets, Gross123.5 123.5 139.7 
Other Intangible Assets
      
Other Intangible Assets, Net      
Other Intangible Assets, Gross23.7 23.7 22.0 
DERMAGRAFTCurrentlyMarketedProductsMember Member
      
Other Intangible Assets, Net      
Finite Lived Intangible Assets Gross$ 710.0 $ 710.0 $ 0